Iranian Scientist Wins APLAR Master Award in Japan
05 December 2025 | 11:15
16:00 - September 23, 2025

Iranian Scientist Wins APLAR Master Award in Japan

TEHRAN (ANA)- Iranian rheumatologist Farhad Shahram from Tehran University of Medical Sciences received the Master Award at the 27th Asia-Pacific League of Associations for Rheumatology (APLAR) Congress in Fukuoka, Japan.
News ID : 9954

The award is presented annually to senior specialists across the Asia-Pacific region who have left a lasting mark on the field, and Shahram, a leading figure in rheumatology research and training, was recognized for his decades of teaching and scientific work.

The Master Award, one of APLAR’s highest honors, underlines his standing among regional pioneers of the discipline.

Shahram has built a career combining rigorous research with mentoring younger doctors. His work at the university’s Rheumatology Research Center has shaped both clinical practice and policy. Colleagues describe him as a scholar who “opened doors” for the next generation while raising the profile of Iranian medicine abroad.

The accolade places him among a select circle of regional specialists, including Iranian rheumatologists Fereydoun Davatchi.

The APLAR strives to propagate and consolidate Rheumatology endeavours in the Asia Pacific region. Towards this end, the APLAR publishes a journal, the APLAR Journal of Rheumatology. The APLAR Congress is the prime meeting organized by the APLAR every year.

The conference brings together slot gacor rheumatologists, internists, orthopaedic surgeons, clinical immunologists, physiatrists, physical and occupational therapists, paediatricians and researchers from allied disciplines on a common platform for deliberations in the region regarding all aspects of musculoskeletal diseases. The APLAR is affiliated to the International League of Associations for Rheumatology (ILAR).

APLAR spearheads the fight against arthritis. APLAR’s mission and goals focus on providing state of the art care to patients with arthritis and other musculoskeletal diseases through the continuing professional development of members, increasing the awareness and understanding about rheumatic diseases, patient advocacy and empowerment, and fostering research in the field of rheumatic diseases.

4155/v

 

 

 

Send comments